Strength goals before drug names
STRENGTHPEPTIDE THERAPY GUIDE
Guide home

Coverage check

A prescription and coverage are separate calls.

Which product, use and plan?

Give the plan an exact product and reason.

Ask about the medicine that has actually been discussed, rather than asking whether the plan covers “peptides”.

  • Is this product on my plan’s covered-drug list?
  • Is it covered for the reason the person treating me is considering it?
  • Does the plan need approval before the prescription is filled?
  • What would I pay for this exact medicine as a pill, shot or other version?

The covered-drug list is called a formulary. Approval from the plan before payment is often called prior authorization.

Medicare’s weight rule depends on the use.

As of September 2026, Medicare’s standard drug benefit excludes medicines when used for weight loss. [A]

Some other medically accepted uses can allow coverage, but the drug list and approval rules of the plan still apply. [A]

Being eligible for consideration does not promise payment. [A]

The temporary weight-care program is separate.

A patient’s share of a covered cost is called a copay.

GLP-1 is a hormone involved in blood sugar and appetite; certain weight and diabetes medicines copy its action. [B]

As of September 2026, eligible people can get certain weight-care drugs through the Medicare GLP-1 Bridge for a monthly copay of $50. [B]

The Bridge runs from July 1, 2026, through December 31, 2027. Its payments to pharmacies are handled separately from your normal Medicare drug plan. [B]

Your $50 payment is excluded when calculating the yearly limit for your own spending under Medicare Part D, the usual prescription-drug benefit. The Bridge provides no additional help with payments to those on low incomes. [B]

As of September 2026, qualifying depends on your weight, other health conditions and Medicare drug plan. You need a prescription and the program’s approval before it pays. [B]

The program is for adults with qualifying Medicare drug coverage. People with type 2 diabetes use normal drug-plan coverage instead; those whose plans paid for a GLP-1 drug during 2026 are ineligible for the Bridge in that year. [B]

Read Medicare’s eligibility and coverage page

Paying without insurance and using a drug-company discount card differ.

A savings card, also called a copay card, is a drug-company discount on what you pay with insurance. It is separate from your insurance card. [C]

As of September 2026, the major weight-drug companies’ copay cards are discounts for people with private insurance. People with Medicare, Medicaid or other government health coverage cannot use these cards. [C]

The card restriction does not ban you from getting the medicine. Some drug-company offers let people with government coverage pay a reduced price without using insurance. [C]

Ask the pharmacist which offer applies to your prescription and how to use it. Ask your plan whether that payment is counted against your deductible or annual cap on costs you pay yourself.

A deductible is the amount you pay before your plan begins to share covered costs.

Return to the question sheet

Source notes for this page

  1. [A]
    CMS: the weight-loss exclusion

    As of September 2026, Medicare’s usual drug benefit excludes weight-loss use. Another accepted medical use still needs your plan’s coverage approval.

  2. [B]
    CMS: the temporary Bridge

    CMS is the Centers for Medicare & Medicaid Services, the agency running the Bridge. As of September 2026, this temporary program does not change the law on normal Medicare drug coverage.

  3. [C]
    Government price portal: offer terms

    As of September 2026, government health coverage rules out these copay cards, but some drug-company offers still allow payment without insurance.